News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

SAC Faces Insider Trading Probe on MedImmune


6/1/2011 7:12:10 AM

SAC Capital Advisors LP faces an insider trading probe from the U.S. Securities and Exchange Commission related to the $15 billion takeover of biotechnology firm MedImmune Inc, the Wall Street Journal reported, citing people familiar with the matter.

The probe is part of a broader SEC inquiry into possible insider trading by hedge funds in connection with the biggest healthcare deals of the last decade, the Journal said.


Read at Wall Street Journal
Read at Bloomberg
Read at Reuters
Read at The Street.com


comments powered by Disqus
MedImmune
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES